BioCentury | Apr 12, 2019
Company News

Sorrento sues NantWorks' Soon-Shiong over alleged 'catch and kill' scheme

...to prevent it from reaching the market. In 2015, Sorrento Therapeutics Inc. (NASDAQ:SRNE) sold its Igdrasol Inc....
BioCentury | Jul 10, 2015
Company News

Sorrento, NantBioScience form oncology JV

...inducer of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) expression. In May, NantWorks acquired Sorrento's IgdraSol Inc....
BioCentury | Jun 22, 2015
Company News

Sorrento, NantWorks deal

...NantWorks will acquire the Igdrasol Inc. subsidiary of Sorrento for $90 million up front and up to...
BioCentury | May 25, 2015
Company News

Samyang, Sorrento deal

...Samyang granted Sorrento’s Igdrasol Inc. subsidiary exclusive rights to commercialize cancer drug Cynviloq in South America. Sorrento...
BioCentury | May 16, 2015
Company News

Sorrento rises on NantWorks deal

...Sorrento Therapeutics Inc. (NASDAQ:SRNE) gained $1.51 (13%) to $13.01 on news that its Igdrasol Inc. subsidiary will...
BioCentury | May 16, 2014
Financial News

Sorrento raises $25 million in follow-on

...to Cynviloq in the U.S., EU, Mexico, Canada and Australia through its September acquisition of Igdrasol Inc....
BioCentury | Feb 17, 2014
Company News

Sorrento, Samyang deal

...Samyang granted EU rights to Sorrento and Igdrasol Inc. and U.S. rights to Igdrasol. Sorrento acquired Igdrasol...
BioCentury | Nov 18, 2013
Company News

Sorrento cancer news

...previously approved products. Sorrento gained exclusive, U.S. rights to Cynviloq through its September acquisition of Igdrasol Inc....
BioCentury | Oct 26, 2013
Financial News

Sorrento raises $30 million, moves to NASDAQ

...previously approved products. Sorrento gained exclusive, U.S. rights to Cynviloq through its September acquisition of Igdrasol Inc....
BioCentury | Oct 21, 2013
Company News

Sherrington Pharmaceuticals, Sorrento deal

...treat NSCLC and mBC. In September, Sorrento acquired exclusive, U.S. rights through the acquisition of Igdrasol Inc....
Items per page:
1 - 10 of 13
BioCentury | Apr 12, 2019
Company News

Sorrento sues NantWorks' Soon-Shiong over alleged 'catch and kill' scheme

...to prevent it from reaching the market. In 2015, Sorrento Therapeutics Inc. (NASDAQ:SRNE) sold its Igdrasol Inc....
BioCentury | Jul 10, 2015
Company News

Sorrento, NantBioScience form oncology JV

...inducer of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) expression. In May, NantWorks acquired Sorrento's IgdraSol Inc....
BioCentury | Jun 22, 2015
Company News

Sorrento, NantWorks deal

...NantWorks will acquire the Igdrasol Inc. subsidiary of Sorrento for $90 million up front and up to...
BioCentury | May 25, 2015
Company News

Samyang, Sorrento deal

...Samyang granted Sorrento’s Igdrasol Inc. subsidiary exclusive rights to commercialize cancer drug Cynviloq in South America. Sorrento...
BioCentury | May 16, 2015
Company News

Sorrento rises on NantWorks deal

...Sorrento Therapeutics Inc. (NASDAQ:SRNE) gained $1.51 (13%) to $13.01 on news that its Igdrasol Inc. subsidiary will...
BioCentury | May 16, 2014
Financial News

Sorrento raises $25 million in follow-on

...to Cynviloq in the U.S., EU, Mexico, Canada and Australia through its September acquisition of Igdrasol Inc....
BioCentury | Feb 17, 2014
Company News

Sorrento, Samyang deal

...Samyang granted EU rights to Sorrento and Igdrasol Inc. and U.S. rights to Igdrasol. Sorrento acquired Igdrasol...
BioCentury | Nov 18, 2013
Company News

Sorrento cancer news

...previously approved products. Sorrento gained exclusive, U.S. rights to Cynviloq through its September acquisition of Igdrasol Inc....
BioCentury | Oct 26, 2013
Financial News

Sorrento raises $30 million, moves to NASDAQ

...previously approved products. Sorrento gained exclusive, U.S. rights to Cynviloq through its September acquisition of Igdrasol Inc....
BioCentury | Oct 21, 2013
Company News

Sherrington Pharmaceuticals, Sorrento deal

...treat NSCLC and mBC. In September, Sorrento acquired exclusive, U.S. rights through the acquisition of Igdrasol Inc....
Items per page:
1 - 10 of 13